The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
about
The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The SGLT2 Inhibitor Dapagliflo ...... lled Type 2 Diabetes Mellitus.
@en
The SGLT2 Inhibitor Dapagliflo ...... lled Type 2 Diabetes Mellitus.
@nl
type
label
The SGLT2 Inhibitor Dapagliflo ...... lled Type 2 Diabetes Mellitus.
@en
The SGLT2 Inhibitor Dapagliflo ...... lled Type 2 Diabetes Mellitus.
@nl
prefLabel
The SGLT2 Inhibitor Dapagliflo ...... lled Type 2 Diabetes Mellitus.
@en
The SGLT2 Inhibitor Dapagliflo ...... lled Type 2 Diabetes Mellitus.
@nl
P2093
P2860
P1433
P1476
The SGLT2 Inhibitor Dapagliflo ...... lled Type 2 Diabetes Mellitus.
@en
P2093
Akira Yoshida
Fumio Miyamoto
Hideaki Jinnouchi
Hiroyuki Nishimura
Katsunori Jinnouchi
Keizo Kajiwara
Kunio Hieshima
Noboru Kurinami
Seigo Sugiyama
Tomio Jinnouchi
P2860
P356
10.2169/INTERNALMEDICINE.0701-17
P577
2018-03-30T00:00:00Z